Ventyx Biosciences
We are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.
Ventyx Biosciences Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
San Francisco, California, USA
